Article
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Nov 2022
von Mehren Margaret, Kane John M, Riedel Richard F, Sicklick Jason K, Pollack Seth M, Agulnik Mark, Bui Marilyn M, Carr-Ascher Janai, Choy Edwin, Connelly Mary, Dry Sarah, Ganjoo Kristen N, Gonzalez Ricardo J, Holder Ashley, Homsi Jade, Keedy Vicki, Kelly Ciara M, Kim Edward, Liebner David, McCarter Martin, McGarry Sean V, Mesko Nathan W, Meyer Christian, Pappo Alberto S, Parkes Amanda M, Petersen Ivy A, Poppe Matthew, Schuetze Scott, Shabason Jacob, Spraker Matthew B, Zimel Melissa, Bergman Mary Anne, Sundar Hema, Hang Lisa E
Abstract excerpt
Gastrointestinal stromal tumors (GIST) are the most common type of soft tissue sarcoma that occur throughout the gastrointestinal tract. Most of these tumors are caused by oncogenic activating mutations in the KIT or PDGFRA genes. The NCCN Guidelines for GIST provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with these tumors. These NCCN Guidelines Insights summarize the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.